In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Penumbra (PEN – Research Report), with a price target of ...
Hosted on MSN6h
Penumbra’s (NYSE:PEN) Q4 Sales Beat EstimatesMedical device company Penumbra (NYSE:PEN) reported in Q4 CY2024, with sales up 10.8% year on year to $315.5 million. On the ...
Hosted on MSN16h
Medical Tools During The Middle AgesMedical instruments have been used for thousands of years. Primitive trephines for performing craniotomies have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback